首页 > 最新文献

Journal of Surgical Research最新文献

英文 中文
P2Y12 Assay Identifies Patients at Risk for Blood Transfusion Following Cardiac Surgery P2Y12检测识别心脏手术后输血风险患者
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-27 DOI: 10.1016/j.jss.2025.10.039
Andrew D. Hawkins MD , Skylar C. Rodgers MD , Andrew M. Young MD , Raymond J. Strobel MD, MSc , Emily Kaplan BA , Steven Young MD , Katherine I. Foley MD MPH , Raza Ahmad MD , Nicholas R. Teman MD

Introduction

Timing of surgical intervention after administration of P2Y12 inhibitors remains a clinical challenge balancing ischemia and bleeding risks. This study assessed whether preoperative P2Y12 assay results correlate with perioperative transfusions, postoperative chest tube (CT) output, and reoperation for bleeding following cardiac surgery.

Methods

All patients undergoing cardiac surgery at a single institution with a preoperative P2Y12 assay value from 2012 to 2022 were included. The P2Y12 assay closest to surgery and relevant bleeding outcomes was obtained. A cutpoint analysis was used to determine a P2Y12 reaction unit (PRU) lab value that identified patients requiring >1 unit of postoperative blood transfusion. A risk-adjusted multivariable regression analyzed bleeding-related outcomes and operative mortality for patients stratified by the PRU cutpoint.

Results

There were 729 patients with a median P2Y12 level of 173.0 PRU, 89% of whom underwent coronary artery bypass grafting. Patients with PRU <194 had a greater decrease in postoperative hematocrit, postoperative day 1 CT output, and average daily CT output. A PRU cutpoint of 101 was selected that classified patients requiring postoperative transfusion of ≥1 unit of packed red blood cell (PRBC). In the risk-adjusted analysis, patients with PRU <101 were found to have higher odds of ≥1 unit postoperative PRBC administration (OR 3.2, 95% CI 1.95-5.44; P < 0.001).

Conclusions

Preoperative P2Y12 assay can help guide the estimation of postoperative bleeding risk. The cutpoint provided by the reference range may be too conservative, and a lower cutpoint can more accurately identify patients at risk of requiring postoperative PRBC transfusion.
应用P2Y12抑制剂后的手术干预时机仍然是平衡缺血和出血风险的临床挑战。本研究评估了术前P2Y12检测结果是否与围手术期输血、术后胸管(CT)输出和心脏手术后出血再手术相关。方法纳入2012 - 2022年在同一医院接受心脏手术且术前P2Y12测定值较高的患者。获得最接近手术和相关出血结果的P2Y12测定。切点分析用于确定P2Y12反应单位(PRU)实验室值,该值可识别需要1单位术后输血的患者。风险调整的多变量回归分析了按PRU切点分层的患者的出血相关结果和手术死亡率。结果729例患者P2Y12中位水平为173.0 PRU, 89%行冠状动脉旁路移植术。PRU <;194患者术后红细胞压积、术后第1天CT输出和平均每日CT输出均有较大下降。PRU切点为101,用于对需要术后输血≥1单位填充红细胞(PRBC)的患者进行分类。在风险调整分析中,PRU <;101患者术后给予≥1单位PRBC的几率更高(OR 3.2, 95% CI 1.95-5.44; P < 0.001)。结论术前P2Y12检测有助于指导术后出血风险的判断。参考范围提供的临界值可能过于保守,较低的临界值可以更准确地识别有术后输血风险的患者。
{"title":"P2Y12 Assay Identifies Patients at Risk for Blood Transfusion Following Cardiac Surgery","authors":"Andrew D. Hawkins MD ,&nbsp;Skylar C. Rodgers MD ,&nbsp;Andrew M. Young MD ,&nbsp;Raymond J. Strobel MD, MSc ,&nbsp;Emily Kaplan BA ,&nbsp;Steven Young MD ,&nbsp;Katherine I. Foley MD MPH ,&nbsp;Raza Ahmad MD ,&nbsp;Nicholas R. Teman MD","doi":"10.1016/j.jss.2025.10.039","DOIUrl":"10.1016/j.jss.2025.10.039","url":null,"abstract":"<div><h3>Introduction</h3><div>Timing of surgical intervention after administration of P2Y12 inhibitors remains a clinical challenge balancing ischemia and bleeding risks. This study assessed whether preoperative P2Y12 assay results correlate with perioperative transfusions, postoperative chest tube (CT) output, and reoperation for bleeding following cardiac surgery.</div></div><div><h3>Methods</h3><div>All patients undergoing cardiac surgery at a single institution with a preoperative P2Y12 assay value from 2012 to 2022 were included. The P2Y12 assay closest to surgery and relevant bleeding outcomes was obtained. A cutpoint analysis was used to determine a P2Y12 reaction unit (PRU) lab value that identified patients requiring &gt;1 unit of postoperative blood transfusion. A risk-adjusted multivariable regression analyzed bleeding-related outcomes and operative mortality for patients stratified by the PRU cutpoint.</div></div><div><h3>Results</h3><div>There were 729 patients with a median P2Y12 level of 173.0 PRU, 89% of whom underwent coronary artery bypass grafting. Patients with PRU &lt;194 had a greater decrease in postoperative hematocrit, postoperative day 1 CT output, and average daily CT output. A PRU cutpoint of 101 was selected that classified patients requiring postoperative transfusion of ≥1 unit of packed red blood cell (PRBC). In the risk-adjusted analysis, patients with PRU &lt;101 were found to have higher odds of ≥1 unit postoperative PRBC administration (OR 3.2, 95% CI 1.95-5.44; <em>P</em> &lt; 0.001).</div></div><div><h3>Conclusions</h3><div>Preoperative P2Y12 assay can help guide the estimation of postoperative bleeding risk. The cutpoint provided by the reference range may be too conservative, and a lower cutpoint can more accurately identify patients at risk of requiring postoperative PRBC transfusion.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 516-523"},"PeriodicalIF":1.7,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reoperative Parathyroidectomy: Recognizing Unique Risk Profiles 再次手术甲状旁腺切除术:认识独特的风险概况
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-27 DOI: 10.1016/j.jss.2025.11.066
Tessa Gruen BS , Tim Kravchenko MD , Theodore Hu MD, MPhil , Aayushi Sinha MS , Steven Xie MD , Catherine B. Jensen MD, MS , Susan C. Pitt MD, MPHS , David T. Hughes MD , Paul G. Gauger MD , Hunter J. Underwood MD

Introduction

Reoperative parathyroidectomy following prior parathyroidectomy, thyroidectomy, or nonendocrine anterior cervical procedures is more complex than initial parathyroidectomy. Limited data exist on how the index cervical operation affects reoperative outcomes. This study aimed to characterize reoperative parathyroidectomy outcomes by index procedure.

Methods

We retrospectively reviewed adult patients who underwent reoperative parathyroidectomy for primary hyperparathyroidism at a tertiary center from 2016 to 2024. Patients were stratified by index procedure: subtotal (≥3 gland removal) parathyroidectomy, focused (single gland removal) parathyroidectomy, total thyroidectomy, hemithyroidectomy, and nonendocrine anterior cervical procedures. Immediate biochemical cure was defined as postexcision intraoperative parathyroid hormone (PTH) <65 pg/mL and surgical failure as final intraoperative PTH >65 pg/mL. Permanent postoperative hypoparathyroidism (POHP) was defined as PTH <6 pg/mL beyond 6 mo. Operative and clinical notes were reviewed for recurrent laryngeal nerve injury, postoperative neck hematoma, and parathyroid autotransplantation.

Results

Among 242 reoperative parathyroidectomy patients, 128 (60%) had prior focused parathyroidectomy, 16 (7.5%) subtotal parathyroidectomy, 33 (16%) total thyroidectomy, 26 (12%) hemithyroidectomy, and 10 (4.1%) nonendocrine anterior cervical procedures. Prior subtotal parathyroidectomy was associated with higher rates of autotransplantation (P < 0.001) and surgical failure (P = 0.03). Time to reoperation was shortest in focused parathyroidectomy patients (P < 0.001). The rate of recurrent laryngeal nerve injury in the overall cohort was 1.9%, and the rate of permanent POHP was 14%.

Conclusions

Reoperative parathyroidectomy has an increased risk profile for POHP regardless of the index procedure. Those with prior subtotal parathyroidectomy are at higher risk of surgical failure and require autotransplantation more often. Reoperative parathyroidectomy should be performed at high-volume centers with thorough preoperative risk discussion and a low threshold for autotransplantation.
在既往甲状旁腺切除术、甲状腺切除术或非内分泌前宫颈手术后再行甲状旁腺切除术比初次甲状旁腺切除术更复杂。关于颈椎指数手术如何影响再手术结果的资料有限。本研究旨在通过指数程序描述甲状旁腺再手术的结果。方法回顾性分析2016年至2024年在某三级中心接受原发性甲状旁腺功能亢进再手术治疗的成年患者。患者按指数手术分层:次全(≥3个腺体切除)甲状旁腺切除术、集中(单个腺体切除)甲状旁腺切除术、甲状腺全切除术、甲状旁腺切除术和非内分泌前宫颈手术。即刻生化治愈定义为手术后术中甲状旁腺激素(PTH)≥65 pg/mL,手术失败定义为术中最终PTH≥65 pg/mL。术后永久性甲状旁腺功能低下(POHP)定义为PTH≥6 pg/mL超过6个月。回顾了喉返神经损伤、术后颈部血肿和甲状旁腺自体移植的手术和临床记录。结果242例再手术甲状旁腺切除术患者中,既往行集中甲状旁腺切除术128例(60%),甲状旁腺次全切除术16例(7.5%),甲状腺全切除术33例(16%),甲状旁腺切除术26例(12%),非内分泌前宫颈手术10例(4.1%)。既往甲状旁腺次全切除术与较高的自体移植率(P < 0.001)和手术失败率(P = 0.03)相关。集中甲状旁腺切除术患者再手术时间最短(P < 0.001)。整个队列中喉返神经损伤的发生率为1.9%,永久性POHP的发生率为14%。结论再手术甲状旁腺切除术增加了POHP的风险,与指数手术无关。先前有甲状旁腺次全切除术的患者手术失败的风险更高,需要自体移植的可能性更大。再次手术甲状旁腺切除术应在大容量中心进行,术前应充分讨论风险,并降低自体移植的阈值。
{"title":"Reoperative Parathyroidectomy: Recognizing Unique Risk Profiles","authors":"Tessa Gruen BS ,&nbsp;Tim Kravchenko MD ,&nbsp;Theodore Hu MD, MPhil ,&nbsp;Aayushi Sinha MS ,&nbsp;Steven Xie MD ,&nbsp;Catherine B. Jensen MD, MS ,&nbsp;Susan C. Pitt MD, MPHS ,&nbsp;David T. Hughes MD ,&nbsp;Paul G. Gauger MD ,&nbsp;Hunter J. Underwood MD","doi":"10.1016/j.jss.2025.11.066","DOIUrl":"10.1016/j.jss.2025.11.066","url":null,"abstract":"<div><h3>Introduction</h3><div>Reoperative parathyroidectomy following prior parathyroidectomy, thyroidectomy, or nonendocrine anterior cervical procedures is more complex than initial parathyroidectomy. Limited data exist on how the index cervical operation affects reoperative outcomes. This study aimed to characterize reoperative parathyroidectomy outcomes by index procedure.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed adult patients who underwent reoperative parathyroidectomy for primary hyperparathyroidism at a tertiary center from 2016 to 2024. Patients were stratified by index procedure: subtotal (≥3 gland removal) parathyroidectomy, focused (single gland removal) parathyroidectomy, total thyroidectomy, hemithyroidectomy, and nonendocrine anterior cervical procedures. Immediate biochemical cure was defined as postexcision intraoperative parathyroid hormone (PTH) &lt;65 pg/mL and surgical failure as final intraoperative PTH &gt;65 pg/mL. Permanent postoperative hypoparathyroidism (POHP) was defined as PTH &lt;6 pg/mL beyond 6 mo. Operative and clinical notes were reviewed for recurrent laryngeal nerve injury, postoperative neck hematoma, and parathyroid autotransplantation.</div></div><div><h3>Results</h3><div>Among 242 reoperative parathyroidectomy patients, 128 (60%) had prior focused parathyroidectomy, 16 (7.5%) subtotal parathyroidectomy, 33 (16%) total thyroidectomy, 26 (12%) hemithyroidectomy, and 10 (4.1%) nonendocrine anterior cervical procedures. Prior subtotal parathyroidectomy was associated with higher rates of autotransplantation (<em>P</em> &lt; 0.001) and surgical failure (<em>P</em> = 0.03). Time to reoperation was shortest in focused parathyroidectomy patients (<em>P</em> &lt; 0.001). The rate of recurrent laryngeal nerve injury in the overall cohort was 1.9%, and the rate of permanent POHP was 14%.</div></div><div><h3>Conclusions</h3><div>Reoperative parathyroidectomy has an increased risk profile for POHP regardless of the index procedure. Those with prior subtotal parathyroidectomy are at higher risk of surgical failure and require autotransplantation more often. Reoperative parathyroidectomy should be performed at high-volume centers with thorough preoperative risk discussion and a low threshold for autotransplantation.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 508-515"},"PeriodicalIF":1.7,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Utility of Ubiquitin Carboxyl-Terminal Hydrolase L1 as a Marker of Hemorrhagic Shock 泛素羧基末端水解酶L1作为失血性休克标志物的应用
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-27 DOI: 10.1016/j.jss.2025.12.003
Gregory C. Wetmore MD, Ellen R. Becker MD, Matthew R. Baucom MD, Adam D. Price MD, Robert C. Shondel BS, Maia P. Smith PhD, Rebecca M. Schuster MS, Timothy A. Pritts MD, PhD, FACS, Michael D. Goodman MD, FACS

Introduction

Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) is used as a biomarker of traumatic brain injury (TBI). However, there is limited data on the use in critically injured or polytrauma patients. In this study, we hypothesized that UCHL1 may also serve as a marker of shock and global hypoperfusion after critical injury.

Methods

Serum samples were collected from 425 intensive care unit-admitted trauma patients. Samples were retrospectively analyzed for UCHL1 by enzyme-linked immunosorbent assay. Supplementary data were collected from medical record review, including TBI and blood transfusion requirement used as a surrogate for hemorrhagic shock.

Results

UCHL1 level was associated with TBI diagnosis at arrival (P = 0.02) but not at 24 or 72 h. UCLH1 was also significantly elevated at higher level transfusion at 24 (rho = 0.21) and 72 (rho = 0.19) h (P < 0.001). In addition, UCHL1 was significantly elevated in the 30-d mortality group at 0, 24, and 72 h (P < 0.04). When compared to lactic acid, a current standard marker of shock and resuscitation, mean lactic acid demonstrated similar associations with elevations at higher level transfusion at 0 (rho = 0.38), 6 (rho = 0.19), and 24 (rho = 0.25) h (P < 0.002). In addition, lactic acid was also elevated in the 30-d mortality group at all time points (P < 0.04).

Conclusions

In critical injury, UCHL1 levels are elevated in both TBI and hemorrhagic shock. Therefore, after severe injury, UCHL1 may also serve as an indicator of global hypoperfusion. The associations of UCHL1 with shock and 30-d mortality could be applied to rapid bedside detection of shock and assessment of resuscitation progression.
泛素羧基末端水解酶L1 (UCHL1)被用作创伤性脑损伤(TBI)的生物标志物。然而,关于在严重损伤或多发创伤患者中的应用的数据有限。在这项研究中,我们假设UCHL1也可能作为严重损伤后休克和全脑灌注不足的标志。方法对425例重症监护病房收治的创伤患者进行血清采集。采用酶联免疫吸附法回顾性分析样品中的UCHL1。补充数据收集自医疗记录回顾,包括创伤性脑损伤和作为失血性休克替代指标的输血需求。结果chl1水平与到达时的TBI诊断相关(P = 0.02),但与24和72 h无关。高水平输血时24 (rho = 0.21)和72 (rho = 0.19) h的UCLH1水平也显著升高(P < 0.001)。此外,30 d死亡组在0、24和72 h时UCHL1显著升高(P < 0.04)。与乳酸(目前休克和复苏的标准指标)相比,平均乳酸与高水平输血时0 (rho = 0.38)、6 (rho = 0.19)和24 (rho = 0.25) h (P < 0.002)时的升高有相似的关联。此外,30 d死亡率组各时间点乳酸水平均升高(P < 0.04)。结论重型颅脑损伤和失血性休克患者UCHL1水平均升高。因此,在严重损伤后,UCHL1也可以作为全脑灌注不足的指标。UCHL1与休克和30天死亡率的关联可用于快速床边检测休克和评估复苏进展。
{"title":"The Utility of Ubiquitin Carboxyl-Terminal Hydrolase L1 as a Marker of Hemorrhagic Shock","authors":"Gregory C. Wetmore MD,&nbsp;Ellen R. Becker MD,&nbsp;Matthew R. Baucom MD,&nbsp;Adam D. Price MD,&nbsp;Robert C. Shondel BS,&nbsp;Maia P. Smith PhD,&nbsp;Rebecca M. Schuster MS,&nbsp;Timothy A. Pritts MD, PhD, FACS,&nbsp;Michael D. Goodman MD, FACS","doi":"10.1016/j.jss.2025.12.003","DOIUrl":"10.1016/j.jss.2025.12.003","url":null,"abstract":"<div><h3>Introduction</h3><div>Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) is used as a biomarker of traumatic brain injury (TBI). However, there is limited data on the use in critically injured or polytrauma patients. In this study, we hypothesized that UCHL1 may also serve as a marker of shock and global hypoperfusion after critical injury.</div></div><div><h3>Methods</h3><div>Serum samples were collected from 425 intensive care unit-admitted trauma patients. Samples were retrospectively analyzed for UCHL1 by enzyme-linked immunosorbent assay. Supplementary data were collected from medical record review, including TBI and blood transfusion requirement used as a surrogate for hemorrhagic shock.</div></div><div><h3>Results</h3><div>UCHL1 level was associated with TBI diagnosis at arrival (<em>P</em> = 0.02) but not at 24 or 72 h. UCLH1 was also significantly elevated at higher level transfusion at 24 (rho = 0.21) and 72 (rho = 0.19) h (<em>P</em> &lt; 0.001). In addition, UCHL1 was significantly elevated in the 30-d mortality group at 0, 24, and 72 h (<em>P</em> &lt; 0.04). When compared to lactic acid, a current standard marker of shock and resuscitation, mean lactic acid demonstrated similar associations with elevations at higher level transfusion at 0 (rho = 0.38), 6 (rho = 0.19), and 24 (rho = 0.25) h (<em>P</em> &lt; 0.002). In addition, lactic acid was also elevated in the 30-d mortality group at all time points (<em>P</em> &lt; 0.04).</div></div><div><h3>Conclusions</h3><div>In critical injury, UCHL1 levels are elevated in both TBI and hemorrhagic shock. Therefore, after severe injury, UCHL1 may also serve as an indicator of global hypoperfusion. The associations of UCHL1 with shock and 30-d mortality could be applied to rapid bedside detection of shock and assessment of resuscitation progression.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 531-539"},"PeriodicalIF":1.7,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abdominal Aortic Trauma Outcomes in a National Trauma Database 国家创伤数据库中的腹主动脉创伤结局
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-27 DOI: 10.1016/j.jss.2025.11.067
Vahe S. Panossian MD , Tiemen E.T. Holtrop MD , Yasmin Arda MD, Ikemsinachi C. Nzenwa MBChB, MSc, Charley Sun BS, Matthew Bartek MD, MPH, Joshua S. Ng-Kamstra MD, Casey M. Luckhurst MD, Michael P. DeWane MD, Haytham MA. Kaafarani MD, MPH, George C. Velmahos MD, PhD, John O. Hwabejire MD, MPH

Introduction

Abdominal aortic trauma (AAT), although rare, is associated with high mortality. This descriptive study aims to assess the outcomes of patients with AAT who received either open repair or endovascular aortic repair (EVAR). We hypothesize that EVAR is associated with lower injury severity and better patient outcomes.

Methods

In this retrospective study, the American College of Surgeons Trauma Quality Improvement Program database (2017-2020) was utilized to identify patients ≥18 y who had AAT and received either open repair or EVAR. The overall mortality until discharge was analyzed based on the mechanism of injury, injury severity, and types of procedures received. Multivariable logistic regression was used to assess the independent association between each variable and in-hospital mortality. Patients who died before arriving at the operating room were excluded.

Results

A total of 369 patients were included, with a median age of 32 y. The mechanisms of injury included gunshot wounds (46.3%), blunt trauma (39.6%), and stab wounds (14.1%). EVAR was performed in 14.9% and open repair in 81.0%. Overall mortality was 47.5%. On multivariable analysis, age ≥65 y (adjusted odds ratio [aOR]; 2.60; 95% confidence interval [CI], 1.09-6.21; P = 0.032), Glasgow Coma Scale ≤8 (aOR, 8.23; 95% CI, 4.50-15.05; P < 0.001), systolic blood pressure <90 mmHg (aOR, 3.76; 95% CI, 2.15-6.59; P < 0.001), blunt trauma (aOR, 3.48; 95% CI, 1.32-9.20; P = 0.012), and gunshot wounds (aOR, 3.87; 95% CI, 1.57-9.50; P = 0.003) were independently associated with increased mortality. EVAR was associated with lower mortality (aOR, 0.33; 95% CI, 0.13-0.83; P = 0.019) compared to open repair.

Conclusions

Among patients who survive the initial injury and make it to the operating room, AAT is still associated with significant mortality. EVAR was independently associated with a lower rate of mortality compared to open repair.
腹主动脉创伤(AAT)虽然罕见,但死亡率高。本描述性研究旨在评估AAT患者接受开放式修复或血管内主动脉修复(EVAR)的结果。我们假设EVAR与较低的损伤严重程度和较好的患者预后有关。方法在这项回顾性研究中,使用美国外科医师学会创伤质量改善计划数据库(2017-2020)来识别≥18岁的AAT患者,并接受开放式修复或EVAR。出院前的总死亡率根据损伤机制、损伤严重程度和所接受的手术类型进行分析。采用多变量logistic回归评估各变量与住院死亡率之间的独立相关性。在到达手术室之前死亡的患者被排除在外。结果共纳入369例患者,中位年龄32岁,伤机制包括枪伤(46.3%)、钝器伤(39.6%)和刀伤(14.1%)。EVAR占14.9%,开放式修复占81.0%。总死亡率为47.5%。在多变量分析中,年龄≥65岁(校正优势比[aOR]; 2.60; 95%可信区间[CI], 1.09-6.21; P = 0.032)、格拉斯哥昏迷量表≤8 (aOR, 8.23; 95% CI, 4.50-15.05; P < 0.001)、收缩压和90mmhg (aOR, 3.76; 95% CI, 2.15-6.59; P < 0.001)、钝性创伤(aOR, 3.48; 95% CI, 1.32-9.20; P = 0.012)和枪伤(aOR, 3.87; 95% CI, 1.57-9.50; P = 0.003)与死亡率增加独立相关。与开放式修复相比,EVAR与较低的死亡率相关(aOR, 0.33; 95% CI, 0.13-0.83; P = 0.019)。结论在初次损伤存活并进入手术室的患者中,AAT仍与显著的死亡率相关。与开放式修复相比,EVAR与较低的死亡率独立相关。
{"title":"Abdominal Aortic Trauma Outcomes in a National Trauma Database","authors":"Vahe S. Panossian MD ,&nbsp;Tiemen E.T. Holtrop MD ,&nbsp;Yasmin Arda MD,&nbsp;Ikemsinachi C. Nzenwa MBChB, MSc,&nbsp;Charley Sun BS,&nbsp;Matthew Bartek MD, MPH,&nbsp;Joshua S. Ng-Kamstra MD,&nbsp;Casey M. Luckhurst MD,&nbsp;Michael P. DeWane MD,&nbsp;Haytham MA. Kaafarani MD, MPH,&nbsp;George C. Velmahos MD, PhD,&nbsp;John O. Hwabejire MD, MPH","doi":"10.1016/j.jss.2025.11.067","DOIUrl":"10.1016/j.jss.2025.11.067","url":null,"abstract":"<div><h3>Introduction</h3><div>Abdominal aortic trauma (AAT), although rare, is associated with high mortality. This descriptive study aims to assess the outcomes of patients with AAT who received either open repair or endovascular aortic repair (EVAR). We hypothesize that EVAR is associated with lower injury severity and better patient outcomes.</div></div><div><h3>Methods</h3><div>In this retrospective study, the American College of Surgeons Trauma Quality Improvement Program database (2017-2020) was utilized to identify patients ≥18 y who had AAT and received either open repair or EVAR. The overall mortality until discharge was analyzed based on the mechanism of injury, injury severity, and types of procedures received. Multivariable logistic regression was used to assess the independent association between each variable and in-hospital mortality. Patients who died before arriving at the operating room were excluded.</div></div><div><h3>Results</h3><div>A total of 369 patients were included, with a median age of 32 y. The mechanisms of injury included gunshot wounds (46.3%), blunt trauma (39.6%), and stab wounds (14.1%). EVAR was performed in 14.9% and open repair in 81.0%. Overall mortality was 47.5%. On multivariable analysis, age ≥65 y (adjusted odds ratio [aOR]; 2.60; 95% confidence interval [CI], 1.09-6.21; <em>P</em> = 0.032), Glasgow Coma Scale ≤8 (aOR, 8.23; 95% CI, 4.50-15.05; <em>P</em> &lt; 0.001), systolic blood pressure &lt;90 mmHg (aOR, 3.76; 95% CI, 2.15-6.59; <em>P</em> &lt; 0.001), blunt trauma (aOR, 3.48; 95% CI, 1.32-9.20; <em>P</em> = 0.012), and gunshot wounds (aOR, 3.87; 95% CI, 1.57-9.50; <em>P</em> = 0.003) were independently associated with increased mortality. EVAR was associated with lower mortality (aOR, 0.33; 95% CI, 0.13-0.83; <em>P</em> = 0.019) compared to open repair.</div></div><div><h3>Conclusions</h3><div>Among patients who survive the initial injury and make it to the operating room, AAT is still associated with significant mortality. EVAR was independently associated with a lower rate of mortality compared to open repair.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 524-530"},"PeriodicalIF":1.7,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145837133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial Disparities in Chemotherapy Response in Pancreatic Cancer: A Landmark Survival Analysis 胰腺癌化疗反应的种族差异:具有里程碑意义的生存分析。
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-24 DOI: 10.1016/j.jss.2025.11.051
K. Kerrick Akinola MD , Varun Pathak MBBS , Christopher Wu MD , Chandler McLeod PhD , Herbert Chen MD , Smita Bhatia MD , J. Bart Rose MD , Andrea Gillis MD, MSPH

Introduction

Racial disparities in pancreatic adenocarcinoma mortality may stem from differences in chemotherapy response. This study examines potential disparities between Black and White patients’ responses to adjuvant chemotherapy.

Methods

Using the National Cancer Database (2010-2019), we analyzed Black and White patients with pancreatic adenocarcinoma who underwent surgery with or without adjuvant therapy. Patients receiving neoadjuvant therapy, radiation, with American Joint Committee on Cancer stage >4, or missing data were excluded. A race-stratified landmark survival analysis was performed at 6 mo post surgery using Kaplan–Meier and Cox proportional hazards models.

Results

Among 22,898 surgical patients, 20,434 were White (89%) and 2464 were Black (11%) and the median follow-up was 19.9 mo. Black patients were younger (65.6 versus 69.0 y), more often female (58% versus 48%), and had higher Charlson-Deyo Comorbidity Index (CCI) scores (≥3: 6.0% versus 4.6%) than White patients. Black patients were less likely to receive adjuvant therapy (58% versus 61%). At 6 mo post surgery, 18,977 patients were alive, with 65% receiving chemotherapy. Cox analysis revealed a significant survival benefit from adjuvant therapy in White patients (hazard ratio = 0.90, 95% confidence interval = 0.87-0.95, P < 0.01); a similar effect was not seen in Black patients (hazard ratio = 0.96, 95% confidence interval = 0.84-1.09, P = 0.52).

Conclusions

Although overall survival is similar, adjuvant chemotherapy was associated with improved survival only in White patients. The lack of observed benefit in Black patients may indicate underlying biological differences warranting further study.
胰腺腺癌死亡率的种族差异可能源于化疗反应的差异。本研究探讨了黑人和白人患者对辅助化疗反应的潜在差异。方法:使用国家癌症数据库(2010-2019),我们分析了接受手术或不接受辅助治疗的黑人和白人胰腺腺癌患者。排除了接受新辅助治疗、放疗、美国癌症联合委员会分期bbbb4或缺少数据的患者。采用Kaplan-Meier和Cox比例风险模型,在术后6个月进行种族分层的里程碑生存分析。结果:在22,898例手术患者中,白人患者20,434例(89%),黑人患者2464例(11%),中位随访时间为19.9个月。黑人患者较年轻(65.6岁对69.0岁),女性患者较多(58%对48%),Charlson-Deyo合并症指数(CCI)评分高于白人患者(≥3:6.0%对4.6%)。黑人患者接受辅助治疗的可能性较小(58%对61%)。术后6个月,18,977例患者存活,65%接受化疗。Cox分析显示,白人患者辅助治疗的生存获益显著(风险比= 0.90,95%可信区间= 0.87-0.95,P < 0.01);黑人患者未见类似效果(风险比= 0.96,95%可信区间= 0.84-1.09,P = 0.52)。结论:虽然总生存率相似,但辅助化疗仅在白人患者中与生存率改善相关。在黑人患者中缺乏观察到的益处可能表明潜在的生物学差异值得进一步研究。
{"title":"Racial Disparities in Chemotherapy Response in Pancreatic Cancer: A Landmark Survival Analysis","authors":"K. Kerrick Akinola MD ,&nbsp;Varun Pathak MBBS ,&nbsp;Christopher Wu MD ,&nbsp;Chandler McLeod PhD ,&nbsp;Herbert Chen MD ,&nbsp;Smita Bhatia MD ,&nbsp;J. Bart Rose MD ,&nbsp;Andrea Gillis MD, MSPH","doi":"10.1016/j.jss.2025.11.051","DOIUrl":"10.1016/j.jss.2025.11.051","url":null,"abstract":"<div><h3>Introduction</h3><div>Racial disparities in pancreatic adenocarcinoma mortality may stem from differences in chemotherapy response. This study examines potential disparities between Black and White patients’ responses to adjuvant chemotherapy.</div></div><div><h3>Methods</h3><div>Using the National Cancer Database (2010-2019), we analyzed Black and White patients with pancreatic adenocarcinoma who underwent surgery with or without adjuvant therapy. Patients receiving neoadjuvant therapy, radiation, with American Joint Committee on Cancer stage &gt;4, or missing data were excluded. A race-stratified landmark survival analysis was performed at 6 mo post surgery using Kaplan–Meier and Cox proportional hazards models.</div></div><div><h3>Results</h3><div>Among 22,898 surgical patients, 20,434 were White (89%) and 2464 were Black (11%) and the median follow-up was 19.9 mo. Black patients were younger (65.6 <em>versus</em> 69.0 y), more often female (58% <em>versus</em> 48%), and had higher Charlson-Deyo Comorbidity Index (CCI) scores (≥3: 6.0% <em>versus</em> 4.6%) than White patients. Black patients were less likely to receive adjuvant therapy (58% <em>versus</em> 61%). At 6 mo post surgery, 18,977 patients were alive, with 65% receiving chemotherapy. Cox analysis revealed a significant survival benefit from adjuvant therapy in White patients (hazard ratio = 0.90, 95% confidence interval = 0.87-0.95, <em>P</em> &lt; 0.01); a similar effect was not seen in Black patients (hazard ratio = 0.96, 95% confidence interval = 0.84-1.09, <em>P</em> = 0.52).</div></div><div><h3>Conclusions</h3><div>Although overall survival is similar, adjuvant chemotherapy was associated with improved survival only in White patients. The lack of observed benefit in Black patients may indicate underlying biological differences warranting further study.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 500-507"},"PeriodicalIF":1.7,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-evaluation of Blood Product Wastage From Massive Transfusion Protocol at a Level 1 Trauma Center: A Retrospective Cohort Study 1级创伤中心大规模输血方案中血液制品浪费的再评估:一项回顾性队列研究。
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-23 DOI: 10.1016/j.jss.2025.11.053
Sandra M. Farach MD, MSPH , Nathan Santiago , Milad Behbahaninia MD , Joby J. Chandy MD , Emma Joiner MSc , Jose J. Diaz MD , Enrico Camporesi MD

Introduction

Massive transfusion protocols (MTPs) are essential in the management of traumatic hemorrhage, enabling timely and standardized blood product delivery. This study evaluated whether blood component wastage after MTP activation has decreased compared with previously published institutional data.

Materials and Methods

We retrospectively reviewed 5072 trauma patients ≥18 y between January 2022 and September 2023, identifying 89 (1.8%) with MTP activation. Demographic and clinical data were analyzed. Wastage rates for packed red blood cells, fresh frozen plasma, and platelets were compared to 2015-2018 institutional data. Transfusion documentation discrepancies between the blood bank and the electronic medical record were also assessed. Continuous variables were analyzed with the Mann–Whitney U test and categorical variables with the chi-square or Fisher's exact test, with significance set at P < 0.05.

Results

Of the 89 patients, 31 (34.8%) had wastage of at least one blood component. There were no significant demographic or clinical differences between patients with and those without wastage, including age, gender, injury type, Glasgow Comma Scale, injury severity score, MTP time, complications, discharge disposition, or mortality. Compared to previously published data, wastage significantly decreased for packed red blood cells (2.2% versus 1.2%), fresh frozen plasma (5.7% versus 2.3%), and platelets (13.7% versus 2.9%), all P < 0.001. Documentation discrepancies occurred in 88.7% of activations, with 25.8% involving >10-unit mismatches.

Conclusions

MTP blood product wastage has significantly decreased, reflecting sustained quality improvement. However, high documentation discrepancies highlight a critical target for process improvement.
大量输血方案(mtp)在创伤性出血的管理中至关重要,可实现及时和标准化的血液制品输送。本研究评估了MTP激活后的血液成分损耗与先前发表的机构数据相比是否有所减少。材料和方法:我们回顾性分析了2022年1月至2023年9月期间5072例≥18岁的创伤患者,发现89例(1.8%)MTP激活。对人口学和临床资料进行分析。将包装红细胞、新鲜冷冻血浆和血小板的流失率与2015-2018年的机构数据进行比较。还对血库和电子病历之间的输血记录差异进行了评估。连续变量分析采用Mann-Whitney U检验,分类变量分析采用卡方检验或Fisher精确检验,P < 0.05为显著性。结果:89例患者中,31例(34.8%)出现至少一种血液成分的浪费。在年龄、性别、损伤类型、格拉斯哥逗号量表、损伤严重程度评分、MTP时间、并发症、出院处置或死亡率等方面,有浪费的患者和没有浪费的患者之间没有显著的人口统计学或临床差异。与先前发表的数据相比,包装红细胞(2.2%对1.2%)、新鲜冷冻血浆(5.7%对2.3%)和血小板(13.7%对2.9%)的浪费显著降低,均P < 0.001。88.7%的激活发生了文档差异,其中25.8%涉及10个单元的不匹配。结论:MTP血液制品浪费明显减少,反映了持续的质量改善。然而,高文档差异突出了过程改进的关键目标。
{"title":"Re-evaluation of Blood Product Wastage From Massive Transfusion Protocol at a Level 1 Trauma Center: A Retrospective Cohort Study","authors":"Sandra M. Farach MD, MSPH ,&nbsp;Nathan Santiago ,&nbsp;Milad Behbahaninia MD ,&nbsp;Joby J. Chandy MD ,&nbsp;Emma Joiner MSc ,&nbsp;Jose J. Diaz MD ,&nbsp;Enrico Camporesi MD","doi":"10.1016/j.jss.2025.11.053","DOIUrl":"10.1016/j.jss.2025.11.053","url":null,"abstract":"<div><h3>Introduction</h3><div>Massive transfusion protocols (MTPs) are essential in the management of traumatic hemorrhage, enabling timely and standardized blood product delivery. This study evaluated whether blood component wastage after MTP activation has decreased compared with previously published institutional data.</div></div><div><h3>Materials and Methods</h3><div>We retrospectively reviewed 5072 trauma patients ≥18 y between January 2022 and September 2023, identifying 89 (1.8%) with MTP activation. Demographic and clinical data were analyzed. Wastage rates for packed red blood cells, fresh frozen plasma, and platelets were compared to 2015-2018 institutional data. Transfusion documentation discrepancies between the blood bank and the electronic medical record were also assessed. Continuous variables were analyzed with the Mann–Whitney <em>U</em> test and categorical variables with the chi-square or Fisher's exact test, with significance set at <em>P</em> &lt; 0.05.</div></div><div><h3>Results</h3><div>Of the 89 patients, 31 (34.8%) had wastage of at least one blood component. There were no significant demographic or clinical differences between patients with and those without wastage, including age, gender, injury type, Glasgow Comma Scale, injury severity score, MTP time, complications, discharge disposition, or mortality. Compared to previously published data, wastage significantly decreased for packed red blood cells (2.2% <em>versus</em> 1.2%), fresh frozen plasma (5.7% <em>versus</em> 2.3%), and platelets (13.7% <em>versus</em> 2.9%), all <em>P</em> &lt; 0.001. Documentation discrepancies occurred in 88.7% of activations, with 25.8% involving &gt;10-unit mismatches.</div></div><div><h3>Conclusions</h3><div>MTP blood product wastage has significantly decreased, reflecting sustained quality improvement. However, high documentation discrepancies highlight a critical target for process improvement.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 486-492"},"PeriodicalIF":1.7,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The First Step Is Knowing: Quantifying Social Need Through Screening in a Pediatric Surgery Clinic 第一步是了解:通过儿科外科诊所的筛查量化社会需求。
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-23 DOI: 10.1016/j.jss.2025.11.055
Paris D. Rollins MD , Sarah King DO , Alicia Majcher MHSA , Byron D. Hughes MD, MPH , Erika A. Newman MD , Erin E. Perone MD

Introduction

Patient characteristics such as race, ethnicity, household income, and insurance status predict morbidity and mortality disparities for numerous pediatric surgical disease processes. Health-related social need (HRSN) screening is increasingly utilized in primary care to connect patients with support services and mitigate health disparities. The purpose of this study was to assess the impact of a novel HRSN screening program in a pediatric surgery clinic.

Materials and Methods

We implemented screening for all new patient encounters in our pediatric surgery ambulatory practice, excluding patients screened elsewhere in our health system within the preceding 12 mo. Patients or caregivers completed a comprehensive screening questionnaire up to 1 mo before their clinic visit and could elect to receive need-specific referrals and institutional resources. Using institutional clinic-level data, we evaluated the screening program's results using descriptive statistics.

Results

We screened 1410 patients in the program's first 24 mo. Patients were predominantly male (788 of 1410, 55.9%), Caucasian (1098 of 1410, 77.9%), and under age 10 (773 of 1410, 54.8%). One in five patients (241 of 1410, 17.1%) screened positive for at least one unmet social need. Virtual care access issues and food insecurity were most frequently reported within the cohort (24.9% and 22.3%, respectively). Respondents who screened positive for unmet need rarely requested assistance (82 of 241, 34.0%). Only 5.8% (82 of 1410) of screenings generated a referral.

Conclusions

Pediatric surgery patients in our catchment area experience high rates of unmet social need. Standardized screening is feasible in an ambulatory surgical care setting and may facilitate early identification of intervenable social risk factors. Further investigation is needed to understand why families frequently declined assistance.
患者的特点,如种族,民族,家庭收入,保险状况预测发病率和死亡率的差异,许多儿科外科疾病的过程。与健康相关的社会需求(HRSN)筛查越来越多地用于初级保健,以将患者与支持服务联系起来,并减轻健康差距。本研究的目的是评估一种新的HRSN筛查方案在儿科外科诊所的影响。材料和方法:我们对所有儿科外科门诊就诊的新患者进行筛查,不包括在过去12个月内在我们卫生系统其他地方进行筛查的患者。患者或护理人员在门诊就诊前1个月完成一份全面的筛查问卷,并可以选择接受特定需求的转诊和机构资源。使用机构临床水平的数据,我们使用描述性统计来评估筛查项目的结果。结果:我们在项目的前24个月筛选了1410例患者。患者主要是男性(1410例中788例,55.9%),高加索(1410例中1098例,77.9%)和10岁以下(1410例中773例,54.8%)。五分之一的患者(1410人中有241人,17.1%)在至少一项未满足的社会需求筛查中呈阳性。在队列中最常报告的是虚拟医疗获取问题和食品不安全(分别为24.9%和22.3%)。对未满足需求筛查呈阳性的应答者很少要求援助(241人中有82人,占34.0%)。只有5.8%(1410人中有82人)的筛查产生了转诊。结论:本区儿科外科患者未满足社会需求的比例较高。标准化筛查在门诊外科护理环境中是可行的,可能有助于早期识别可干预的社会风险因素。需要进一步调查,以了解为什么家庭经常拒绝援助。
{"title":"The First Step Is Knowing: Quantifying Social Need Through Screening in a Pediatric Surgery Clinic","authors":"Paris D. Rollins MD ,&nbsp;Sarah King DO ,&nbsp;Alicia Majcher MHSA ,&nbsp;Byron D. Hughes MD, MPH ,&nbsp;Erika A. Newman MD ,&nbsp;Erin E. Perone MD","doi":"10.1016/j.jss.2025.11.055","DOIUrl":"10.1016/j.jss.2025.11.055","url":null,"abstract":"<div><h3>Introduction</h3><div>Patient characteristics such as race, ethnicity, household income, and insurance status predict morbidity and mortality disparities for numerous pediatric surgical disease processes. Health-related social need (HRSN) screening is increasingly utilized in primary care to connect patients with support services and mitigate health disparities. The purpose of this study was to assess the impact of a novel HRSN screening program in a pediatric surgery clinic.</div></div><div><h3>Materials and Methods</h3><div>We implemented screening for all new patient encounters in our pediatric surgery ambulatory practice, excluding patients screened elsewhere in our health system within the preceding 12 mo. Patients or caregivers completed a comprehensive screening questionnaire up to 1 mo before their clinic visit and could elect to receive need-specific referrals and institutional resources. Using institutional clinic-level data, we evaluated the screening program's results using descriptive statistics.</div></div><div><h3>Results</h3><div>We screened 1410 patients in the program's first 24 mo. Patients were predominantly male (788 of 1410, 55.9%), Caucasian (1098 of 1410, 77.9%), and under age 10 (773 of 1410, 54.8%). One in five patients (241 of 1410, 17.1%) screened positive for at least one unmet social need. Virtual care access issues and food insecurity were most frequently reported within the cohort (24.9% and 22.3%, respectively). Respondents who screened positive for unmet need rarely requested assistance (82 of 241, 34.0%). Only 5.8% (82 of 1410) of screenings generated a referral.</div></div><div><h3>Conclusions</h3><div>Pediatric surgery patients in our catchment area experience high rates of unmet social need. Standardized screening is feasible in an ambulatory surgical care setting and may facilitate early identification of intervenable social risk factors. Further investigation is needed to understand why families frequently declined assistance.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 493-499"},"PeriodicalIF":1.7,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145827911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Music for Preventing Postoperative Delirium in Elderly Hip Fracture Patients 音乐预防老年髋部骨折术后谵妄的成本-效果
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-20 DOI: 10.1016/j.jss.2025.11.062
Thomas L.A. Dirven MD , Antonia S. Becker MD , Heleen A. van den Brandeler BSc , Victor X. Fu MD PhD , Johannes Jeekel MD PhD , Markus Klimek MD PhD , Michael H.J. Verhofstad MD PhD , Marten J. Poley PhD

Introduction

Postoperative delirium (POD) is a major health issue associated with considerable health-care costs. Perioperative music is a promising intervention that decreases the risk of delirium. This study investigates whether perioperative music is a cost-effective intervention for preventing POD in elderly hip fracture patients.

Methods

The analysis is based on a multicenter randomized controlled trial (Dutch Trial Register ID: NTR7036). A total of 399 patients aged 65 y or older who underwent acute hip fracture surgery were included. The music group received prerecorded music, whereas the control group received standard-of-care. The primary outcomes were delirium incidence and health-care costs during primary admission and follow-up until 90 d after admission. The secondary outcomes included the Delirium Observational Screening Scale, nursing home admissions, and functional independence.

Results

POD occurred significantly less often in the music group compared to the control group (14 (7.4%) versus 29 (13.8%), P = 0.039) during admission. Primary hospital admission costs were comparable between the music group and the control group (€7749; 95% confidence interval [CI]: 7256-8290 vs. €7723; 95% CI: 7219-8230; mean difference = €27). In addition, the total costs were comparable between both groups (music group €12,078; 95% CI: 10,470-13,733 vs. control group €11,941; 95% CI: 10,701-13,130; mean difference €136). The cost of preventing one case of POD with the music intervention was €415 for the time horizon of the primary admission.

Conclusions

Considering the potential reduction in POD and the comparable costs, music appears to be a cost-effective intervention for preventing POD in elderly hip fracture patients.
术后谵妄(POD)是一个主要的健康问题,与大量的医疗保健费用相关。围手术期音乐是一种很有前途的干预措施,可以降低谵妄的风险。本研究探讨围手术期音乐对于预防老年髋部骨折患者POD是否具有成本效益。方法分析基于一项多中心随机对照试验(荷兰试验注册号:NTR7036)。共纳入399例65岁及以上接受急性髋部骨折手术的患者。音乐组听的是预先录制好的音乐,而对照组听的是标准护理。主要结局是首次入院和入院后90 d随访期间谵妄发生率和医疗费用。次要结果包括谵妄观察筛选量表、疗养院入院和功能独立性。结果入院时音乐组发生spod的次数明显少于对照组(14例(7.4%)vs 29例(13.8%),P = 0.039)。初级住院费用在音乐组和对照组之间具有可比性(7749欧元;95%置信区间[CI]: 7256-8290欧元对7723欧元;95%置信区间:7219-8230欧元;平均差异= 27欧元)。此外,两组之间的总成本具有可比性(音乐组12,078欧元,95% CI: 10,470-13,733,对照组11,941欧元,95% CI: 10,701-13,130,平均差136欧元)。在初次入院的时间范围内,音乐干预预防一例POD的成本为415欧元。结论考虑到POD的潜在降低和相应的费用,音乐似乎是预防老年髋部骨折患者POD的一种经济有效的干预措施。
{"title":"Cost-Effectiveness of Music for Preventing Postoperative Delirium in Elderly Hip Fracture Patients","authors":"Thomas L.A. Dirven MD ,&nbsp;Antonia S. Becker MD ,&nbsp;Heleen A. van den Brandeler BSc ,&nbsp;Victor X. Fu MD PhD ,&nbsp;Johannes Jeekel MD PhD ,&nbsp;Markus Klimek MD PhD ,&nbsp;Michael H.J. Verhofstad MD PhD ,&nbsp;Marten J. Poley PhD","doi":"10.1016/j.jss.2025.11.062","DOIUrl":"10.1016/j.jss.2025.11.062","url":null,"abstract":"<div><h3>Introduction</h3><div>Postoperative delirium (POD) is a major health issue associated with considerable health-care costs. Perioperative music is a promising intervention that decreases the risk of delirium. This study investigates whether perioperative music is a cost-effective intervention for preventing POD in elderly hip fracture patients.</div></div><div><h3>Methods</h3><div>The analysis is based on a multicenter randomized controlled trial (Dutch Trial Register ID: NTR7036). A total of 399 patients aged 65 y or older who underwent acute hip fracture surgery were included. The music group received prerecorded music, whereas the control group received standard-of-care. The primary outcomes were delirium incidence and health-care costs during primary admission and follow-up until 90 d after admission. The secondary outcomes included the Delirium Observational Screening Scale, nursing home admissions, and functional independence.</div></div><div><h3>Results</h3><div>POD occurred significantly less often in the music group compared to the control group (14 (7.4%) <em>versus</em> 29 (13.8%), <em>P</em> = 0.039) during admission. Primary hospital admission costs were comparable between the music group and the control group (€7749; 95% confidence interval [CI]: 7256-8290 vs. €7723; 95% CI: 7219-8230; mean difference = €27). In addition, the total costs were comparable between both groups (music group €12,078; 95% CI: 10,470-13,733 vs. control group €11,941; 95% CI: 10,701-13,130; mean difference €136). The cost of preventing one case of POD with the music intervention was €415 for the time horizon of the primary admission.</div></div><div><h3>Conclusions</h3><div>Considering the potential reduction in POD and the comparable costs, music appears to be a cost-effective intervention for preventing POD in elderly hip fracture patients.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 474-485"},"PeriodicalIF":1.7,"publicationDate":"2025-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145787887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Dilemma of Dog Bite Wounds: Primary versus Delayed Closure 狗咬伤的困境:原发性与延迟愈合
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-19 DOI: 10.1016/j.jss.2025.11.036
Omar Hejazi MD, Mohammad Al Ma'ani MD, Muhammad Haris Khurshid MD, Francisco Castillo-Diaz MD, Louis J. Magnotti MD, MS, FACS, Bellal Joseph MD, FACS

Introduction

The World Health Organization recommends delayed closure of bite wounds, despite controversial studies that advocate or prohibit this practice. This study aimed to compare the outcomes of primary versus delayed closure of pediatric dog bite wounds.

Methods

This is a retrospective analysis of the trauma registry at a level I trauma center. Pediatric (<18 y) patients with dog bite wounds were included. Patients were stratified based on wound management into primary versus delayed closure groups. Primary outcomes were infectious complications, including fever, local abscess, local erythema (>2 cm), edema, purulent discharge, and a white blood cell count of >12,000. Multivariable regression analyses were performed to identify the independent effect of primary versus delayed closure on the outcomes, adjusting for potential confounding factors.

Results

A total of 86 pediatric patients were identified. The mean (standard deviation) age was 8 (5) and 50% were male. Head and neck were the most involved body region (80.2%), followed by upper extremities (16.3%). The median wound size was 4 [2-7] cm ranging from 0.1 to 26 cm. There was no difference in terms of wound size (P = 0.607) and depth (0.607) between primary and delayed groups. Overall, 66.3% of patients received antibiotics on arrival and 73.3% were discharged on antibiotics. Overall, 54 (62.8%) underwent primary wound closure. Overall, 11.6% developed infectious complications, with no difference between study groups (primary closure: 11.1% versus delayed closure: 12.5%, P = 0.846). The time to closure was not associated with adjusted odds of infectious complications (adjusted odds ratio 0.875, 95% CI [0.23-3.37], P = 0.875).

Conclusions

Despite the current recommendations, there was no association between the timing of wound closure and infectious complications among pediatric patients presenting with dog bites, regardless of wound size and depth. Future efforts should focus on selected wounds that might benefit from delayed closure despite the purported risks of cosmetic effects.
世界卫生组织建议延迟关闭咬伤,尽管有争议的研究支持或禁止这种做法。本研究的目的是比较儿童狗咬伤的初步愈合和延迟愈合的结果。方法回顾性分析某一级创伤中心创伤登记资料。包括小儿(18岁)犬咬伤患者。患者根据伤口处理分为初级缝合组和延迟缝合组。主要结局是感染并发症,包括发热、局部脓肿、局部红斑(2厘米)、水肿、脓性分泌物和白细胞计数1.2万。进行多变量回归分析,以确定初次缝合与延迟缝合对结果的独立影响,并对潜在的混杂因素进行调整。结果共发现86例患儿。平均(标准差)年龄为8(5)岁,50%为男性。头颈部是受累最多的部位(80.2%),其次是上肢(16.3%)。中位创面大小为4 [2-7]cm, 0.1 ~ 26 cm。在创面大小(P = 0.607)和深度(0.607)方面,原发性组和迟发性组之间没有差异。总体而言,66.3%的患者到达时使用抗生素,73.3%的患者出院时使用抗生素。总的来说,54例(62.8%)接受了初次伤口愈合。总体而言,11.6%的患者出现了感染并发症,研究组之间没有差异(原发性闭合:11.1%与延迟闭合:12.5%,P = 0.846)。缝合时间与感染并发症的调整后几率无相关性(调整后优势比为0.875,95% CI [0.23-3.37], P = 0.875)。结论:尽管有目前的建议,但在被狗咬伤的儿科患者中,无论伤口大小和深度如何,伤口愈合的时间与感染并发症之间没有关联。未来的努力应该集中在可能受益于延迟缝合的伤口上,尽管据称有美容效果的风险。
{"title":"The Dilemma of Dog Bite Wounds: Primary versus Delayed Closure","authors":"Omar Hejazi MD,&nbsp;Mohammad Al Ma'ani MD,&nbsp;Muhammad Haris Khurshid MD,&nbsp;Francisco Castillo-Diaz MD,&nbsp;Louis J. Magnotti MD, MS, FACS,&nbsp;Bellal Joseph MD, FACS","doi":"10.1016/j.jss.2025.11.036","DOIUrl":"10.1016/j.jss.2025.11.036","url":null,"abstract":"<div><h3>Introduction</h3><div>The World Health Organization recommends delayed closure of bite wounds, despite controversial studies that advocate or prohibit this practice. This study aimed to compare the outcomes of primary <em>versus</em> delayed closure of pediatric dog bite wounds.</div></div><div><h3>Methods</h3><div>This is a retrospective analysis of the trauma registry at a level I trauma center. Pediatric (&lt;18 y) patients with dog bite wounds were included. Patients were stratified based on wound management into primary <em>versus</em> delayed closure groups. Primary outcomes were infectious complications, including fever, local abscess, local erythema (&gt;2 cm), edema, purulent discharge, and a white blood cell count of &gt;12,000. Multivariable regression analyses were performed to identify the independent effect of primary <em>versus</em> delayed closure on the outcomes, adjusting for potential confounding factors.</div></div><div><h3>Results</h3><div>A total of 86 pediatric patients were identified. The mean (standard deviation) age was 8 (5) and 50% were male. Head and neck were the most involved body region (80.2%), followed by upper extremities (16.3%). The median wound size was 4 [2-7] cm ranging from 0.1 to 26 cm. There was no difference in terms of wound size (<em>P</em> = 0.607) and depth (0.607) between primary and delayed groups. Overall, 66.3% of patients received antibiotics on arrival and 73.3% were discharged on antibiotics. Overall, 54 (62.8%) underwent primary wound closure. Overall, 11.6% developed infectious complications, with no difference between study groups (primary closure: 11.1% <em>versus</em> delayed closure: 12.5%, <em>P</em> = 0.846). The time to closure was not associated with adjusted odds of infectious complications (adjusted odds ratio 0.875, 95% CI [0.23-3.37], <em>P</em> = 0.875).</div></div><div><h3>Conclusions</h3><div>Despite the current recommendations, there was no association between the timing of wound closure and infectious complications among pediatric patients presenting with dog bites, regardless of wound size and depth. Future efforts should focus on selected wounds that might benefit from delayed closure despite the purported risks of cosmetic effects.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 467-473"},"PeriodicalIF":1.7,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145787782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prehospital Experience With Left Ventricular Assist Devices 院前使用左心室辅助装置的经验
IF 1.7 3区 医学 Q2 SURGERY Pub Date : 2025-12-18 DOI: 10.1016/j.jss.2025.11.049
Emily L. Larson MD , Reed Jenkins MD , Alexandra Rizaldi BS , Raymond Zhang EMT , John Thompson EMT , Ruben Troncoso MD MPH , Asa Margolis DO MPH , Ahmet Kilic MD

Introduction

Advancements in the heart failure armamentarium have increased left ventricular assist device (LVAD) use, including in emergency medical services (EMS).

Materials and Methods

We performed a retrospective review of patients with LVADs transported to the emergency department by 911 EMS from 2017 to 2021. Patient LVAD characteristics, EMS characteristics and interventions, and outcomes were reported.

Results

There were 75 EMS transports of 25 patients. LVADs were destination therapy for 87% and used for a median 2.3 y. Patients most frequently presented for chest pain, with LVAD alarms present for 15%. An LVAD assessment was present for 24%. The LVAD team was contacted for 8% and hospital notified for 56%. Eight percent were priority one (immediate life-threat). Median length of stay was 4 d, with 81% admitted. One-year survival after EMS transport was 74.8% (95% confidence interval 61.6%-90.9%), with four in-hospital deaths and 39% returning to the emergency department within 30 d.

Conclusions

This study highlights LVAD patients’ frequent high-acuity presentation to EMS, with associated high mortality and emergency department return. Additionally, it reveals gaps in the EMS care of these patients and provides an important opportunity to partner with EMS agencies to improve clinician education and the care of LVAD patients.
心力衰竭设备的进步增加了左心室辅助装置(LVAD)的使用,包括在紧急医疗服务(EMS)中。材料和方法我们回顾性分析了2017年至2021年通过911 EMS运送到急诊科的lvad患者。报告患者LVAD特征、EMS特征、干预措施和结果。结果25例患者共75次急诊转运。87%的患者将LVAD作为最终治疗手段,使用时间中位数为2.3年。患者最常表现为胸痛,15%的患者出现LVAD警报。24%的患者有LVAD评估。联系LVAD团队的占8%,通知医院的占56%。8%是一级(直接危及生命)。中位住院时间为4天,81%的患者入院。EMS转运后1年生存率为74.8%(95%可信区间61.6%-90.9%),其中4例院内死亡,39%在30 d内返回急诊室。结论本研究强调LVAD患者频繁出现高急性症状,与高死亡率和高急诊室复诊相关。此外,它揭示了这些患者在EMS护理方面的差距,并提供了与EMS机构合作改善临床医生教育和LVAD患者护理的重要机会。
{"title":"Prehospital Experience With Left Ventricular Assist Devices","authors":"Emily L. Larson MD ,&nbsp;Reed Jenkins MD ,&nbsp;Alexandra Rizaldi BS ,&nbsp;Raymond Zhang EMT ,&nbsp;John Thompson EMT ,&nbsp;Ruben Troncoso MD MPH ,&nbsp;Asa Margolis DO MPH ,&nbsp;Ahmet Kilic MD","doi":"10.1016/j.jss.2025.11.049","DOIUrl":"10.1016/j.jss.2025.11.049","url":null,"abstract":"<div><h3>Introduction</h3><div>Advancements in the heart failure armamentarium have increased left ventricular assist device (LVAD) use, including in emergency medical services (EMS).</div></div><div><h3>Materials and Methods</h3><div>We performed a retrospective review of patients with LVADs transported to the emergency department by 911 EMS from 2017 to 2021. Patient LVAD characteristics, EMS characteristics and interventions, and outcomes were reported.</div></div><div><h3>Results</h3><div>There were 75 EMS transports of 25 patients. LVADs were destination therapy for 87% and used for a median 2.3 y. Patients most frequently presented for chest pain, with LVAD alarms present for 15%. An LVAD assessment was present for 24%. The LVAD team was contacted for 8% and hospital notified for 56%. Eight percent were priority one (immediate life-threat). Median length of stay was 4 d, with 81% admitted. One-year survival after EMS transport was 74.8% (95% confidence interval 61.6%-90.9%), with four in-hospital deaths and 39% returning to the emergency department within 30 d.</div></div><div><h3>Conclusions</h3><div>This study highlights LVAD patients’ frequent high-acuity presentation to EMS, with associated high mortality and emergency department return. Additionally, it reveals gaps in the EMS care of these patients and provides an important opportunity to partner with EMS agencies to improve clinician education and the care of LVAD patients.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"317 ","pages":"Pages 439-445"},"PeriodicalIF":1.7,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145787833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Surgical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1